This how much of a snake oil salesman Irwin Simon is - he says below that Tilray will enter the YS by acquiring an costing player - and focus on TWO states?
Has he forgotten that maybe Tilray COULD have if he hadn't spent $225 million on Medmen.
Now - after spending half a billion on Medmen and Hexo, Tilray has No CASH to service both its upcoming debt AND buy a U.S. MSO of any signiificance - without massive dilution.
But the kicker that shows exactly how out of touch Simon is - like buying 8 craft brewers in a dying sector - I are the facts and reality of the California market he labs on entering.
Does Simon not follow the cannabis sector???
California is in the same boat as Canada - oversupply, too much product and the black market, California is the last place looking for NEW players.
And New York??? Even the existing BIG players like Cresco, Cura and Trulieve are JUST NIW getting additional licences - who does Simple Simon think he's going to buy?
The $30 million dollar man has no clue
"in the U.S. expeditiously, whether through a greenfield approach or by acquiring an existing player in the States, Simon says.
The CEO says Tilray would target the big markets on both coasts, including California and New York."